Madrigal Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Madrigal Pharmaceuticals patents 11 in total

Status Patent
Application
Utility: METHODS OF TREATING LIVER DISORDERS OR LIPID DISORDERS WITH A THR-BETA AGONIST External link
Filling date: 26 Sep 2025 Issue date: 28 Oct 2021
Application
Utility: METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF External link
Filling date: 26 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: METHODS OF TREATING NEUROLOGICAL DISEASES AND DISORDERS External link
Filling date: 26 Sep 2025 Issue date: 13 May 2021
Application
Utility: SOLID FORMS OF 2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENY- L)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBONITRILE External link
Filling date: 26 Sep 2025 Issue date: 29 Apr 2021
Application
Utility: TARGETED THERAPEUTICS External link
Filling date: 26 Sep 2025 Issue date: 25 Mar 2021
Application
Utility: TARGETED THERAPEUTICS External link
Filling date: 26 Sep 2025 Issue date: 8 Oct 2020
Application
Utility: TARGETED THERAPEUTICS External link
Filling date: 26 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: METHODS OF TREATING LIVER DISORDERS OR LIPID DISORDERS WITH A THR-BETA AGONIST External link
Filling date: 26 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: COMBINATION THERAPIES COMPRISING TARGETED THERAPEUTICS External link
Filling date: 26 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: METHODS OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF External link
Filling date: 26 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: TARGETED THERAPEUTICS External link
Filling date: 26 Sep 2025 Issue date: 17 Oct 2019

Showing 1 to 11 of 11 patents.